Home » interviews » Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Founder & CEO, Sapala Organics

Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Founder & CEO, Sapala Organics

Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Sapala Organics

  • November 24, 2025

Interviews

India is b
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Cancer tre
Cancer treatment must move beyond one-size-fits-all decisions: Dr. Manjiri Bakre, CEO and Founder, OncoStem Diagnostics
We plan to
We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
View More

Appointments

Pfizer CFO Dave Denton to exit
Pfizer CFO Dave Denton to exit
Saurabh Gambhir elevated to Chief Strategy Officer (Global) at Cipla
Saurabh Gambhir elevated to Chief Strategy Officer (Global) at Cipla
Dr. Dhananjay Kumar Tiwary gets additional charge as Managing Director of BIRAC
Dr. Dhananjay Kumar Tiwary gets additional charge as Managing Director of BIRAC
View More

Startup

Lumos Health opens applications for second cohort of HealthTech and MedTech startups
Lumos Health opens applications for second cohort of HealthTech and MedTech startups
Hoola Health raises $5 million to expand child-centric paediatric care
Hoola Health raises $5 million to expand child-centric paediatric care
HealthFab raises Rs 20 crore in Series A funding from Atomic Capital
HealthFab raises Rs 20 crore in Series A funding from Atomic Capital
View More

Digitization

CENT expands to Delhi-NCR with new clinical prevention centre in Gurugram
CENT expands to Delhi-NCR with new clinical prevention centre in Gurugram
proRITHM named among top 4 AI-based healthcare technologies
proRITHM named among top 4 AI-based healthcare technologies
Life sciences firms move from AI pilots to scaled adoption, finds KPMG Global Tech Report 2026
Life sciences firms move from AI pilots to scaled adoption, finds KPMG Global Tech Report 2026
View More

Upcoming E-conference
July 17, 2026 Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma

Latest Stories

Shilpa Biologicals' PartnerPower promises real-time transparency in biologics development

KIMS Hospitals launches RENOVA Oncology Institute in Bengaluru

Teva submits FDA application for experimental Tourette syndrome treatment ecopipam

FDA advisory panel backs Moderna flu vaccine candidate for older adults

FDA clears 131 drugs as global pharma approval momentum rebounds in 2025

Opinion
NCAHP Act has built backbone of India’s healthcare workforce: Nalin Saluja, Co-Founder & CTO, Virohan
NCAHP Act has built backbone of India’s healthcare workforce: Nalin Saluja, Co-Founder & CTO, Virohan
Insect biotech as India's next deeptech opportunity: Ankit Alok Bagaria, Co-founder and CEO, Loopworm
Insect biotech as India's next deeptech opportunity: Ankit Alok Bagaria, Co-founder and CEO, Loopworm

Interviews
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International
Cancer treatment must move beyond one-size-fits-all decisions: Dr. Manjiri Bakre, CEO and Founder, OncoStem Diagnostics
Cancer treatment must move beyond one-size-fits-all decisions: Dr. Manjiri Bakre, CEO and Founder, OncoStem Diagnostics
Dr. Manjiri Bakre CEO and Founder, OncoStem Diagnostics
We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
Akhil Ravi Chief Executive Officer, Aurigene Pharmaceutical Services Limited

Packaging